Granzyme B + CD8 + T cells with terminal differentiated effector signature determine multiple sclerosis progression.

J Neuroinflammation · 2023 · PMC10236809 · PMID 37268957

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Comparison of patients with RRMS, CD8 T cells from SPMS patients were identified a decreasing trend in TCRs diversity (Fig. 3 C).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.